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RENAL HEMODYNAMIC DYSFUNCTION plays a central role in the pathophysiological consequences of insulin-dependent diabetes mellitus (IDDM). Specifically, glomerular hyperfiltration (and/or consequent maladaptations to this process) is believed to ultimately engender reductions in glomerular filtration rate and the development of diabetic glomerulopathy. Although some investigators have advanced the postulate that increased nitric oxide (NO) production contributes to the renal hemodynamic maladaptations of IDDM (6, 23, 28, 39) other studies have failed to discern any effect of IDDM on the renal hemodynamic response to nitric oxide synthase (NOS) inhibition (17, 22, 26, 34) . Data from our laboratory indicate that NOS inhibition exerts a diminished impact on renal arteriolar baseline diameter in streptozotocin (STZ)-treated rats and that superoxide dismutase (SOD) normalizes the diameter response to NOS inhibition (30) . These observations suggest that superoxide anion accelerates NO degradation in IDDM, thus reducing the functional impact of endogenous NO on the renal microvasculature in IDDM.
In addition to its direct vasodilator effect, endogenously produced NO normally tempers renal vascular responsiveness to a variety of constrictor stimuli (7, 27, 33, 36) . In particular, the counterbalancing influences of ANG II and NO on the renal microvasculature appear to represent primary determinants of renal perfusion and glomerular filtration. It is easy to envision that an imbalance in the vasoactive actions of these paracrine substances could contribute to the disruption of renal hemodynamic function in IDDM. Indeed, a recent analysis of glomerular filtration rate responses to NOS inhibition and/or ANG II receptor blockade suggested that combined alterations in ANG II and NO may contribute to the hyperfiltration in STZ rats (26) . However, functional interactions between ANG II and NO have not yet been probed by direct means in renal arterioles from diabetic animals. The purpose of the present study was to test the postulate that IDDM is associated with an impaired modulatory impact of NO on ANG II-induced renal arteriolar vasoconstriction. Additional experiments assessed the ability of SOD to restore defective NO modulation of afferent arteriolar ANG II responsiveness in kidneys from diabetic rats. metabolic cages (Nalgene, Nalge, Rochester, NY) for 2 days immediately before the terminal experiment. The total volume of urine collected during the final 24-h period was centrifuged (to remove sediment) and stored at Ϫ70°C. These samples were assayed for creatinine concentration by a picric acid-based microplate assay (35) .
In Vitro Blood-Perfused Juxtamedullary Nephron Technique
Two to three weeks after induction of diabetes, experiments were performed by using the in vitro blood-perfused juxtamedullary nephron technique (11) . The rat was anesthetized with pentobarbital sodium (50 mg/kg Nembutal ip; Abbott Laboratories, North Chicago, IL), and an angiotensinconverting enzyme inhibitor (enalaprilat, 2 mg ia; Merck Research Laboratories, Rahway, NJ) was administered to suppress endogenous ANG II formation and its impact on vascular tone. Thirty minutes later, the right renal artery was cannulated via the superior mesenteric artery. This procedure initiated in situ perfusion of the kidney with Tyrode solution containing 52 g/l dialyzed BSA and D-glucose at a concentration of either 90 mg/dl (Sham rats) or 300 mg/dl (STZ rats). The rat was then exsanguinated via a carotid arterial cannula into a heparinized syringe, and the kidney was harvested for in vitro study. Renal perfusion was maintained throughout the dissection procedure needed to reveal the tubules, glomeruli, and vasculature of juxtamedullary nephrons. Ligatures were placed around the distal segments of the large arterial branches that supplied the exposed microvasculature.
When necessary to obtain an adequate volume of blood for renal perfusion, an additional blood-donor rat was anesthetized, treated with enalaprilat, subjected to acute bilateral nephrectomy, and exsanguinated via a carotid arterial cannula into a heparinized syringe. The collected blood was pooled with that harvested from the kidney donor and processed to remove leukocytes and platelets (19) . The resulting perfusate was stirred continuously in a closed reservoir that was pressurized under 95% O 2 -5% CO 2 , thus providing both oxygenation and the driving force for perfusion of the dissected kidney at a constant renal arterial pressure of 110 mmHg. Kidneys from STZ rats were perfused with blood from STZ rats, and kidneys from Sham rats were perfused with blood from Sham rats.
The renal perfusion chamber was warmed, and the tissue surface was superfused with Tyrode solution containing 10 g/l BSA at 37°C. Except when otherwise noted, this bathing solution contained 300 mg/dl glucose for experiments utilizing STZ kidneys and 90 mg/dl glucose for experiments using Sham kidneys. The renal microvasculature was transilluminated on the stage of a compound microscope, and a single afferent or efferent arteriole was selected for study on the basis of visibility and blood flow. Video images of each microvessel were generated continuously and stored on videotape for later analysis. In one experiment in which two vessels could be visualized within the same field of view, responses of both vessels were recorded simultaneously and analyzed separately during videotape playback.
Experimental Protocols
Effect of NOS inhibition on ANG II-induced arteriolar vasoconstriction. Arteriolar diameter responses to increasing concentrations of ANG II (Sigma Chemical) were evaluated by exposing kidneys from Sham and STZ rats to the following superfusate bathing solutions: 1) Tyrode solution alone (5-10 min); 2) Tyrode solution containing 0.1, 1.0, and 10 nM ANG II (3 min at each concentration); and 3) Tyrode solution alone (10 min). After this recovery period, endogenous NOS inhibition was achieved by addition of 100 µM N -nitro-L-arginine (L-NNA; Aldrich Chemical, Milwaukee, WI) to the Tyrode bathing solution, as described previously (31) . Juxtamedullary afferent arteriolar diameter responses to 100 µM L-NNA are apparent within 5 min, maximal at 10 min, and stable for Ͼ30 min thereafter (19) . Accordingly, a 15-min L-NNA treatment period preceded initiation of the second ANG II exposure sequence (0.1, 1.0, and 10 nM ANG II; 3 min each) in the continued presence of L-NNA. This was followed by a recovery period during which the tissue was exposed to Tyrode solution containing L-NNA alone. Imposition of two consecutive ANG II exposure sequences according to this protocol (but in the absence of L-NNA) evokes indistinguishable juxtamedullary arteriolar diameter responses in normal kidneys, even at peptide concentrations 10-fold higher than those employed in the present study (8) .
Effect of reduced extracellular glucose concentration on ANG II-NO interactions in IDDM. Additional experiments addressed the possibility that an acute decrease in extracellular glucose toward normal levels might restore NO modulation of ANG II responses in STZ rats. Afferent or efferent arteriolar diameter responses to ANG II were documented in STZ kidneys before and during L-NNA treatment according to the protocol described above, except that all bath solutions contained 90 mg/dl glucose.
Effect of SOD on ANG II-NO interactions. The contribution of endogenous superoxide anion to the altered NO modulation of arteriolar ANG II responses in IDDM was explored through the use of acute SOD treatment. SOD from bovine erythrocytes (Sigma Chemical; 3,100-5,100 U/mg) was added to the perfusate blood to achieve a final concentration of 150 U/ml. This concentration of SOD has been reported to achieve complete scavenging of extracellular superoxide anion (16) . Experiments were performed by using kidneys from both Sham rats and STZ rats perfused with SOD-supplemented blood (treatment groups designated ShamϩSOD and STZϩSOD, respectively). Afferent arteriolar diameter responses to ANG II were obtained in these kidneys before and during L-NNA treatment, according to the protocol described above.
Data Analysis
Arteriolar lumen diameter was measured from videotaped images at 12-s intervals from a single point along the length of the vessel. The average diameter during the final minute of each treatment period was utilized for statistical analysis by repeated-measures ANOVA or Friedman repeated-measures ANOVA on ranks, as appropriate, followed by a NewmanKeuls test. Simple between-group comparisons were performed by using the unpaired t-test. All statistical computations were performed utilizing the SigmaStat 2.03 software package (SPSS, Chicago, IL). Statistical significance was defined as P values Ͻ0.05. All data are reported as means Ϯ SE (n ϭ number of arterioles, unless specified otherwise). Table 1 summarizes the salient characteristics of Sham and STZ rats utilized in the present study. At the time of injection of either STZ or vehicle, the rats receiving STZ weighed somewhat more than those receiving vehicle (Sham rats). However, because Sham rats gained more weight (80 Ϯ 7 g; n ϭ 20 rats) than STZ rats (24 Ϯ 5 g; n ϭ 31 rats; P Ͻ 0.05) during the ensuing 2-to 3-wk period, the Sham rats weighed significantly more than STZ rats at the time of the microvascular function studies. The average blood glucose concentration for all rats before injection was 81 Ϯ 2 mg/dl (n ϭ 51 rats). Multiple measurements of blood glucose concentration during the 17 Ϯ 1 days between initial injection (of STZ or vehicle) and the terminal experiment confirmed that STZ rats were significantly hyperglycemic relative to Sham rats. The STZ rats were polydipsic and polyuric, as evidenced by increases in water intake and urine flow during the 24-h before the microvascular function studies (during which time the animals were housed in metabolic cages), and had elevated creatinine excretion rates. Table 2 summarizes arteriolar diameters in the various treatment groups before (untreated) and during NOS inhibition (100 µM L-NNA). As reported previously (32) , baseline afferent arteriolar diameter was significantly increased in kidneys from STZ rats, but efferent arteriolar diameter did not differ significantly between Sham and STZ rats. The afferent arteriolar dilation associated with IDDM remained evident in SOD-treated STZ kidneys but did not achieve statistical significance in STZ kidneys bathed in low-glucose (90 mg/dl) solution. Figure 1A illustrates the effect of L-NNA on ANG II-induced constriction of afferent arterioles in kidneys from Sham rats. Addition of 1 and 10 nM ANG II to the bathing solution reduced lumen diameter to 17.2 Ϯ 1.6 and 9.9 Ϯ 2.2 µm, respectively (n ϭ 6), and removal of ANG II from the bathing solution restored diameter to 19.8 Ϯ 1.4 µm [not significant (NS) vs. baseline]. Addition of L-NNA to the bathing solution decreased afferent arteriolar diameter by 6.0 Ϯ 1.4 µm ( Table 2) . During continued L-NNA treatment, the same concentrations of ANG II reduced afferent arteriolar lumen diameter to 9.7 Ϯ 1.5 µm (1 nM (n ϭ 6) (n ϭ 6) (n ϭ 6) STZ 300 25.9 Ϯ 1.3 † 18.3 Ϯ 1.5* 27.0 Ϯ 2.6 24.6 Ϯ 1.
RESULTS

Animal Characteristics
Effect of NOS Inhibition on ANG II-Induced Arteriolar Vasoconstriction
Values are means Ϯ SE. NOS, nitric oxide synthase (100 µm N -nitro-L-arginine; L-NNA). SOD, kidneys perfused with blood containing 150 U/ml superoxide dismutase (SOD). * P Ͻ 0.05 vs. Untreated. † P Ͻ 0.05 vs. Sham. ‡ P Ͻ 0.05 vs. ShamϩSOD. (Table 2) . During L-NNA treatment, 1 and 10 nM ANG II significantly reduced efferent arteriolar diameter to 16.1 Ϯ 3.5 and 10.4 Ϯ 3.3 µm, respectively, and diameter was restored to 18.2 Ϯ 3.0 µm during the recovery period (NS vs. L-NNA baseline). The efferent arteriolar response to 10 nM ANGII was significantly amplified by L-NNA treatment in kidneys from Sham rats ( Fig. 2A) .
In kidneys from STZ rats, efferent arteriolar diameter was unaffected by 0.1 and 1 nM ANG II before L-NNA treatment but decreased significantly to 21.1 Ϯ 2.7 µm on exposure to 10 nM ANG II (Fig. 2B) . These responses did not differ significantly from those observed in efferent arterioles from Sham rats. Removal of ANG II from the bathing solution restored efferent arteriolar diameter to 27.0 Ϯ 2.7 µm (100 Ϯ 3% of baseline). The tendency for L-NNA to decrease efferent diameter failed to achieve statistical significance in kidneys from STZ rats (Ϫ2.4 Ϯ 1.3 µm; Table 2 ). However, efferent arteriolar responses to 10 nM ANG II were exaggerated significantly by L-NNA treatment, with lumen diameter averaging 14.5 Ϯ 3.7 µm under these conditions. Removal of ANG II from the L-NNAcontaining bathing solution restored efferent diameter to 22.9 Ϯ 2.2 µm (NS vs. L-NNA baseline). Thus the modulatory impact of L-NNA on efferent arteriolar ANG II responsiveness was sustained in kidneys from STZ rats.
Effect of Reduced Extracellular Glucose Concentration on ANG II-NO Interactions in IDDM
In experiments performed exclusively using kidneys from STZ rats, afferent and efferent arteriolar function was assessed by using bath solutions containing 90 mg/dl glucose. Under these conditions that impose on STZ kidneys an acute restoration of extracellular glucose concentration toward normal levels, arteriolar baseline diameters did not differ significantly from those observed in either Sham kidneys or STZ kidneys studied in the high-glucose environment (Table 2 ). Figure 3 illustrates the effects of L-NNA on arteriolar ANG II responsiveness in STZ kidneys studied using 90 mg/dl glucose bath solutions. Afferent arteriolar diameter averaged 18.4 Ϯ 2.6 µm during exposure to 1 nM ANG II and further declined to 10.9 Ϯ 2.3 µm when exposed to 10 nM ANG II (P Ͻ 0.05 vs. baseline). Removal of ANG II from the bath restored diameter to 22.3 Ϯ 1.3 µm (NS vs baseline). Subsequent L-NNA treatment reduced afferent arteriolar diameter by 4.4 Ϯ 1.4 µm ( Table 2) . During continued exposure to L-NNA in the 90 mg/dl glucose bath, ANG II reduced afferent arteriolar lumen diameter in STZ kidneys to 13.3 Ϯ 1.7 µm (1 nM) and 7.2 Ϯ 0.9 µm (10 nM). These responses to ANG II in the presence of L-NNA did not differ from those observed in the same arterioles before L-NNA treatment (Fig. 3A) . Thus the inability of L-NNA treatment to allow exaggerated afferent arteriolar ANG II responsiveness remained evident in STZ kidneys bathed in solutions containing 90 mg/dl glucose.
The effect of reduced bath glucose concentration on efferent arteriolar responses in STZ kidneys is shown in Fig. 3B . Efferent arteriolar diameter averaged 22.2 Ϯ 2.2 µm during exposure to 1 nM ANG II (NS vs. baseline) and further declined to 16.8 Ϯ 3.3 µm when exposed to 10 nM ANG II (P Ͻ 0.05 vs. baseline). Removal of ANG II from the bath restored efferent diameter to 23.3 Ϯ 2.4 µm (NS vs. baseline). Subsequent L-NNA treatment only reduced efferent arteriolar diameter by 2.1 Ϯ 0.7 µm (Table 2 ). During L-NNA (Fig. 1A) , the afferent arteriolar responses to 1 and 10 nM ANG II in ShamϩSOD kidneys were exaggerated significantly by L-NNA treatment (Fig. 4A) .
Effect of SOD on NO-ANG II Interactions
Afferent arteriolar diameter tended to be greater in STZϩSOD kidneys than in STZ kidneys without SOD supplementation; however, this trend did not achieve statistical significance (Table 2) . Addition of 1 and 10 nM ANG II to the solution bathing STZϩSOD kidneys reduced afferent diameter to 27.3 Ϯ 1.9 and 16.8 Ϯ 1.9 µm, respectively (Fig. 4B) , responses that did not differ significantly from those in STZ kidneys without SOD supplementation. On removal of ANG II from the bath, afferent arteriolar diameter was restored to 29.6 Ϯ 1.9 µm (NS vs. baseline). Addition of L-NNA to the bathing solution decreased afferent diameter in STZϩSOD kidneys by 4.2 Ϯ 0.4 µm ( Table 2 ; NS vs. STZ without SOD or Sham). During continued L-NNA treatment, the same concentrations of ANG II (1 and 10 nM) reduced afferent arteriolar lumen diameter to 20.5 Ϯ 2.1 and 10.9 Ϯ 1.2 µm, respectively. These responses to 1 and 10 nM ANG II significantly exceeded those observed in the same vessels before L-NNA treatment. After removal of ANG II from the bathing solution, but in the continued presence of L-NNA, afferent diameter was restored to 23.6 Ϯ 2.0 µm (NS vs. L-NNA baseline). Therefore, SOD supplementation restored the ability of L-NNA to amplify afferent arteriolar vasoconstrictor responses to exogenous ANG II in kidneys from STZ rats.
DISCUSSION
Considerable attention has focused on elucidating the role of ANG II in the maladaptive renal hemodynamic events accompanying IDDM. Conventional wisdom asserts that the renin-angiotensin system is sup- pressed during the early stages of IDDM, as evidenced by the frequent observation of reduced plasma renin activity under these conditions. However, ACE inhibition retards development of glomerular injury in IDDM (25, 43) , and most evidence indicates that this occurs through an ANG II-dependent mechanism (2, 37, 40). These observations suggest that the renal hemodynamic impact of endogenous ANG II may be exaggerated in IDDM (21, 42) , despite normal or reduced renal tissue ANG II levels. Increased ANG II sensitivity may occur as a consequence of the hyperfiltration process (or may arise despite the development of hyperfiltration) and could contribute to the subsequent development of diabetic glomerulopathy and end-stage renal disease. The results of the present study support the contention that renal arteriolar ANG II responsiveness is retained during the early stage of a IDDM in a moderately hyperglycemic rat model characterized by polydipsia, polyuria, and increased creatinine excretion (consistent with hyperfiltration). Moreover, our data reveal that the normal modulatory influence of NO on afferent arteriolar ANG II responsiveness is absent under these conditions (but is restored by superoxide dismutase), whereas NO modulation of ANG II-induced efferent arteriolar constriction remains intact.
Numerous studies have revealed that the renal hemodynamic impact of ANG II is exaggerated by NOS inhibition, suggesting that endogenous NO tempers the renal vasoconstrictor impact of ANG II under normal conditions. In accord with this contention, juxtamedullary afferent and efferent arteriolar diameter responses to ANG II are exaggerated by treatment with L-NNA (18, 19) . In the present study, the modulatory impact of 100 µM L-NNA on ANG II responsiveness was confirmed in both afferent and efferent arterioles from Sham rats. At this concentration, L-NNA is maximally effective in reducing afferent arteriolar baseline diameter and abolishing the afferent arteriolar vasodilator response to acetylcholine in our experimental setting (18, 31) . The modulatory impact of L-NNA on ANG II responsiveness cannot be attributed to the L-NNAinduced decrease in diameter per se, because preconstriction with norepinephrine does not exaggerate juxtamedullary afferent arteriolar ANG II responsiveness (19) . Thus the increased ANG II responsiveness observed during L-NNA treatment indicates that endogenous NO normally tempers ANG II-induced renal vasoconstrictor responsiveness.
IDDM is generally reported to impair renal vasodilator responses to acetylcholine and other endotheliumdependent agents (14, 15, 20, 41) . However, the effect of IDDM on the increase in renal vascular resistance evoked by NOS inhibition remains controversial (6, 17, 22, 23, 26, 28, 34, 39) . We previously observed markedly diminished afferent and efferent arteriolar vasoconstrictor responses to L-NNA in kidneys from STZ rats (30) , suggesting that the tonic functional impact of NO on the renal microvasculature is decreased in IDDM. In the present study, however, the effect of NOS inhibition on baseline afferent arteriolar diameter remained intact in STZ kidneys, whereas efferent arteriolar responses were abated. At least two phenomena may contribute to this discrepancy with our previous data. First, the present study employed acute enalaprilat treatment to facilitate evaluation of arteriolar responsiveness to exogenous ANG II, whereas our previous study was performed in the setting of an intact reninangiotensin system. In light of the complex interplay between tissue ANG II and NO levels under normal conditions, and our incomplete understanding of the status of the intrarenal renin-angiotensin system in IDDM (1), the impact of enalaprilat treatment on NO-dependent baseline tone in the present studies cannot be reasonably estimated. Second, our earlier study specifically targeted the tonic influence of endogenous NO on baseline diameter by generating L-NNA concentration-response relationships in kidneys from Sham and STZ rats, whereas the present study employed a complex experimental design that optimized our ability to detect NO modulation of ANG II responses through paired observations. This latter design is not a powerful means of detecting between-group differences in the effect of NOS inhibition on baseline diameter. Nevertheless, coupled with the use of enalaprilat-treated tissue to provide a functional baseline of reduced tissue ANG II formation, the design of the present studies provides a powerful assessment of the modulatory influence of NO on contractile responses to exogenous ANG II.
Short-term exposure to high-glucose media exaggerates ANG II-induced constriction of rabbit afferent arterioles by inhibiting the modulatory action of NO (4) . The results of the present study extend this observation by demonstrating that the usual effect of L-NNA to allow enhanced afferent arteriolar ANG II responsiveness is absent in kidneys from diabetic rats. NO modulation of afferent arteriolar ANG II responsiveness was also absent in STZ kidneys studied during an acute reduction of extracellular glucose concentration toward normal levels, indicating that this phenomenon is not osmotic in origin. Pflueger and co-workers (34) have documented loss of the ability of L-NNA to promote renal vasoconstrictor responses to adenosine in IDDM. Thus it appears that neither basal nor agoniststimulated NO levels are sufficient to provide the normal modulatory impact of NO on renal vasoconstrictor events in IDDM. Although this phenomenon can be expected to promote exaggerated renal vasoconstrictor responsiveness to ANG II in IDDM, afferent arteriolar ANG II responses observed in the absence of NOS inhibition did not differ between Sham and STZ kidneys in the present study. The multiple paracrine influences on the renal microvasculature, as well as alterations in endogenous ANG II synthesis, AT 1 receptor density, and/or intracellular signaling events are all potential mechanisms through which the IDDM might influence the impact of ANG II on the renal microvasculature. We suspect that the loss of NO-dependent modulation of afferent arteriolar ANG II responsiveness in IDDM is offset by the diminished response of this arteriolar segment to membrane depolarization and opening of voltage-gated Ca 2ϩ channels (9), pro-cesses that are critical in eliciting the constrictor response to ANG II. Baseline afferent arteriolar tone is also heavily dependent on membrane potential and Ca 2ϩ influx through these channels (10). Hence, decreased functional expression of voltage-gated Ca 2ϩ channels and/or a hyperpolarizing shift in membrane potential (e.g., increased K ϩ conductance) could engender the reduced preglomerular resistance characteristic of diabetic hyperfiltration, despite a reduced microvascular impact of endogenous NO.
Ichihara and co-workers (18) have provided evidence that both NOS-1 and NOS-3 provide NO that influences afferent arteriolar basal tone, whereas NOS-3 is the primary source of NO that modulates afferent arteriolar ANG II responsiveness. Hence, one could postulate that reduced NOS-3 expression might underlie the decreased impact of NO on afferent tone (30) and the absence of NO modulation of afferent arteriolar contractile responsiveness evident in IDDM. This scenario is improbable in light of the increase in afferent arteriolar NOS-3 immunostaining and NADPH-diaphorase staining that has been described at 1, 2, and 4 wk after induction of IDDM (38) . It is more likely that increased degradation, rather than decreased synthesis, underlies the reduced bioavailability of NO in IDDM. Chronic exposure of cultured endothelial cells to a high-glucose environment promotes production of superoxide anion (12) which, in a virtually diffusionlimited reaction, reacts with NO to form peroxynitrite. Although not representing a significant pathway for NO degradation under normal conditions, peroxynitrite formation gains functional significance as a means of reducing the half-life of NO in states of oxidant stress such as hypertension or IDDM. Accordingly, although not altering responses in normal vessels, treatment with SOD or free radical scavengers ameliorates the impaired endothelium-dependent vasodilator function accompanying IDDM in a variety of nonrenal vascular beds (3, 14, 24, 29) and in renal interlobar arteries (13) . We previously reported the ability of exogenous SOD to restore normal afferent and efferent arteriolar diameter responses to NOS blockade in IDDM (30) . This observation suggests that superoxide anion accumulation promotes a reduction in ambient NO concentration and its impact on the renal microvasculature in IDDM, even in the face of normal or increased NO synthesis. A deleterious impact of superoxide anion on the renal microvascular actions of NO in IDDM is further implicated by our present observation that exogenous SOD unmasked a modulator effect of endogenous NO on ANG II-induced afferent arteriolar constriction in STZ kidneys, while not altering ANG II responses in kidneys from Sham rats. Thus superoxide anion acting in the vicinity of the afferent arteriole appears responsible for the impaired availability of NO to temper ANG II-induced constriction of that vascular segment.
Although the influence on NO on efferent arteriolar baseline diameter is suppressed in STZ rats (30) , the results of the present study reveal that the modulatory impact of NO on efferent arteriolar ANG II responsiveness is preserved. This surprising observation may relate to the distinct sources of the NO that influences juxtamedullary arteriolar baseline diameter and constrictor responsiveness. Through the use of inhibitors that are selective for NOS-1 or nonselective (affecting all 3 NOS isoforms), Ichihara et al. (18) provided evidence that baseline diameters of juxtamedullary efferent arterioles are maintained under the tonic influence of NO derived from both NOS-3 (from endothelial sources) and NOS-1 [expressed in macula densa cells and the efferent arteriolar endothelium (5)]. Moreover, their work indicated that juxtamedullary efferent arteriolar ANG II responsiveness is modulated solely by NO produced through the enzymatic activity of NOS-1 (18) . It is possible that the NO produced by NOS-1 is either anatomically or physiologically protected from reaction with superoxide anion in IDDM, or that superoxide anion production in IDDM is relatively compartmentalized at endothelial sites and thus reacts predominantly with NO derived from endothelial sources (mainly NOS-3). Further experiments are necessary to address these postulates.
In summary, the results of the present study confirm that NOS inhibition allows exaggerated juxtamedullary arteriolar diameter responses to ANG II, reflecting the modulatory impact of endogenous NO on agonistinduced vasoconstriction. NO modulation of afferent arteriolar ANG II responsiveness was absent in afferent arterioles from diabetic rats but was unmasked by acute treatment with superoxide dismutase. NO modulation of efferent arteriolar ANG II responsiveness was retained in kidneys from diabetic rats, perhaps due to compartmentalization of either NO or superoxide anion production. These observations support the contention that the renal microvascular impact of endogenous NO is suppressed in IDDM, largely as a result of NO degradation via reaction with superoxide anion.
